First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic ...

Verve Medical today announced the successful treatment of the first patient in a trial of its hypertension treatment.

The one-year data shows that 80% of people benefited from the device. It's implanted in the ankle and stimulates a nerve.

An interdisciplinary team from the University Hospitals Cologne and Bonn have conducted the first prospective study to ...

Verve Medical’s therapy targets overactive renal nerves US-based Verve Medical has reported the treatment of the first patient in its pilot trial for uncontrolled hypertension with a renal pelvic ...

An interdisciplinary team from the University Hospitals Cologne and Bonn have conducted the first prospective study to investigate whether very early intervention in unborn children with congenital ...

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50; Many respondents report undergoing ...

Only three of the 14 counties in north-central Florida provide full access to obstetric care. Six have low access to ...

For Deion Sanders, the "Coach Prime" persona has always been defined by an indomitable physical presence and a relentless pace. However, as the 2026 college football season appr ...

PLEASANTON, CA, UNITED STATES, March 13, 2026 /EINPresswire.com/ -- More than 500,000 people go to the emergency room ...